CVS Health Corporation with ticker code (CVS) now have 25 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $93.00 and $57.00 calculating the average target share price we see $68.35. (at the time of writing). Given that the stocks previous close was at $51.76 and the analysts are correct then there would likely be a percentage uptick in value of 32.1%. There is a 50 day moving average of $58.78 and the 200 day moving average is $61.80. The company has a market cap of 65.14B. The price for the stock stands currently at: $49.58 USD
The potential market cap would be $86,009,215,468 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 12.58, revenue per share of $290.20 and a 2.37% return on assets.
CVS Health Corporation, together with its subsidiaries, is a diversified health solutions company. The Company’s segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Its Health Care Benefits offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and diagnostic testing.
